{"id":"https://openalex.org/W1551425670","doi":"https://doi.org/10.1111/bph.12518","title":"GluN2C / GluN2D subunit\u2010selective NMDA receptor potentiator CIQ reverses MK \u2010801\u2010induced impairment in prepulse inhibition and working memory in Y \u2010maze test in mice","display_name":"GluN2C / GluN2D subunit\u2010selective NMDA receptor potentiator CIQ reverses MK \u2010801\u2010induced impairment in prepulse inhibition and working memory in Y \u2010maze test in mice","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-13","ids":{"openalex":"https://openalex.org/W1551425670","doi":"https://doi.org/10.1111/bph.12518","mag":"1551425670","pmid":"https://pubmed.ncbi.nlm.nih.gov/24236947","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3969090"},"language":"en","primary_location":{"id":"doi:10.1111/bph.12518","doi":"https://doi.org/10.1111/bph.12518","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.12518","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.12518","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1551425670"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.12518","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001167400","display_name":"Pratyush S. Suryavanshi","orcid":"https://orcid.org/0000-0001-6904-7294","observed_orcids":["https://orcid.org/0000-0001-6904-7294"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P S Suryavanshi","raw_affiliation_strings":["Department of Pharmacology, Creighton University Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Creighton University Omaha, NE, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071230914","display_name":"Rajesh Ramesh Ugale","orcid":"https://orcid.org/0000-0002-0185-8186","observed_orcids":["https://orcid.org/0000-0002-0185-8186"]},"institutions":[{"id":"https://openalex.org/I26285277","display_name":"Guru Ghasidas Vishwavidyalaya","ror":"https://ror.org/05bvxq496","country_code":"IN","type":"education","lineage":["https://openalex.org/I26285277"]}],"countries":["IN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R R Ugale","raw_affiliation_strings":["Department of Pharmacology School of Pharmacy Guru Ghasidas Central University Bilaspur India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology School of Pharmacy Guru Ghasidas Central University Bilaspur India","institution_ids":["https://openalex.org/I26285277"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030781289","display_name":"Deniz Yilmazer\u2010Hanke","orcid":"https://orcid.org/0000-0003-1483-0286","observed_orcids":["https://orcid.org/0000-0003-1483-0286"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Yilmazer\u2010Hanke","raw_affiliation_strings":["Department of Biomedical Sciences Creighton University Omaha NE USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences Creighton University Omaha NE USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007216606","display_name":"Dustin J. Stairs","orcid":"https://orcid.org/0000-0002-5946-4104","observed_orcids":["https://orcid.org/0000-0002-5946-4104"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D J Stairs","raw_affiliation_strings":["Department of Psychology, Creighton University, Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychology, Creighton University, Omaha, NE, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028610293","display_name":"Shashank Manohar Dravid","orcid":"https://orcid.org/0000-0002-9912-8148","observed_orcids":["https://orcid.org/0000-0002-9912-8148"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"S M Dravid","raw_affiliation_strings":["Department of Pharmacology, Creighton University Omaha, NE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Creighton University Omaha, NE, USA","institution_ids":["https://openalex.org/I114493937"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5028610293"],"corresponding_institution_ids":["https://openalex.org/I114493937"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":5.9363,"has_fulltext":true,"cited_by_count":112,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96880168,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"171","issue":"3","first_page":"799","last_page":"809"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9146000146865845,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9146000146865845,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.04899999871850014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.01860000006854534,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nmda-receptor-hypofunction","display_name":"NMDA receptor hypofunction","score":0.7910000085830688},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9769999980926514},{"id":"https://openalex.org/keywords/prepulse-inhibition","display_name":"prepulse inhibition","score":0.9020000100135803},{"id":"https://openalex.org/keywords/working-memory","display_name":"working memory","score":0.8429999947547913},{"id":"https://openalex.org/keywords/mk-801","display_name":"MK-801","score":0.9380000233650208},{"id":"https://openalex.org/keywords/methamphetamine","display_name":"methamphetamine","score":0.9390000104904175},{"id":"https://openalex.org/keywords/hyperlocomotion","display_name":"hyperlocomotion","score":0.8769999742507935},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.8379999995231628},{"id":"https://openalex.org/keywords/positive-allosteric-modulators","display_name":"positive allosteric modulators","score":0.9049999713897705},{"id":"https://openalex.org/keywords/nmda-receptor-co-agonist","display_name":"NMDA receptor co-agonist","score":0.699999988079071},{"id":"https://openalex.org/keywords/cognitive-symptoms","display_name":"cognitive symptoms","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C164718446","wikidata":"https://www.wikidata.org/wiki/Q7234839","display_name":"Potentiator","level":2,"score":0.7841606140136719},{"id":"https://openalex.org/C141421786","wikidata":"https://www.wikidata.org/wiki/Q1128897","display_name":"Prepulse inhibition","level":3,"score":0.520761251449585},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39057278633117676},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2212493121623993},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.12218067049980164},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.11815306544303894},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006948","descriptor_name":"Hyperkinesis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006948","descriptor_name":"Hyperkinesis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008570","descriptor_name":"Memory, Short-Term","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D009433","descriptor_name":"Neural Inhibition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D016291","descriptor_name":"Dizocilpine Maleate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018782","descriptor_name":"Maze Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/bph.12518","doi":"https://doi.org/10.1111/bph.12518","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.12518","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.12518","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3969090","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3969090/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:24236947","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24236947","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1111/bph.12518","doi":"https://doi.org/10.1111/bph.12518","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.12518","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.12518","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4105956641","display_name":"Replacing an Animal Resource Facility Cage Washer.","funder_award_id":"G20RR024001","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"}],"funders":[{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1551425670.pdf","grobid_xml":"https://content.openalex.org/works/W1551425670.grobid-xml"},"referenced_works_count":63,"referenced_works":["https://openalex.org/W144253663","https://openalex.org/W1538147469","https://openalex.org/W1545972494","https://openalex.org/W1593555249","https://openalex.org/W1659075574","https://openalex.org/W1885682256","https://openalex.org/W1914381346","https://openalex.org/W1916800927","https://openalex.org/W1969451153","https://openalex.org/W1970448316","https://openalex.org/W1980967004","https://openalex.org/W1984049384","https://openalex.org/W1984305433","https://openalex.org/W1997962734","https://openalex.org/W2000534710","https://openalex.org/W2001306967","https://openalex.org/W2001555806","https://openalex.org/W2008020964","https://openalex.org/W2009971242","https://openalex.org/W2013079953","https://openalex.org/W2013514700","https://openalex.org/W2013868610","https://openalex.org/W2014608077","https://openalex.org/W2018224009","https://openalex.org/W2018273027","https://openalex.org/W2022809683","https://openalex.org/W2028884770","https://openalex.org/W2034101922","https://openalex.org/W2034965090","https://openalex.org/W2038590075","https://openalex.org/W2039182248","https://openalex.org/W2040856930","https://openalex.org/W2053006968","https://openalex.org/W2053726422","https://openalex.org/W2053938654","https://openalex.org/W2062367401","https://openalex.org/W2065169750","https://openalex.org/W2070163925","https://openalex.org/W2070873320","https://openalex.org/W2072709259","https://openalex.org/W2073239561","https://openalex.org/W2082113217","https://openalex.org/W2086537218","https://openalex.org/W2089299823","https://openalex.org/W2090287898","https://openalex.org/W2094186688","https://openalex.org/W2094492844","https://openalex.org/W2101626807","https://openalex.org/W2102092558","https://openalex.org/W2102656567","https://openalex.org/W2108696245","https://openalex.org/W2139400978","https://openalex.org/W2141014036","https://openalex.org/W2144244720","https://openalex.org/W2145728950","https://openalex.org/W2146488263","https://openalex.org/W2155125375","https://openalex.org/W2158137297","https://openalex.org/W2164850765","https://openalex.org/W2170461909","https://openalex.org/W2171357629","https://openalex.org/W2172060122","https://openalex.org/W2218580750"],"related_works":["https://openalex.org/W2554377090","https://openalex.org/W2285097562","https://openalex.org/W2520208312","https://openalex.org/W4387647711","https://openalex.org/W407039082","https://openalex.org/W4280509680","https://openalex.org/W2789594857","https://openalex.org/W3175872830","https://openalex.org/W2170461909","https://openalex.org/W2945412053"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,219],"PURPOSE:":[2],"Despite":[3],"ample":[4],"evidence":[5],"supporting":[6],"the":[7,17,42,166,182,207],"N-methyl-D-aspartate":[8],"receptor":[9,32,55],"(NMDAR)":[10],"hypofunction":[11],"hypothesis":[12,25],"of":[13,19,30,94,97,114,120,143,227],"schizophrenia,":[14],"progress":[15],"in":[16,44,58,103,128,131,148,162,212,215,243],"development":[18],"effective":[20],"therapeutics":[21],"based":[22],"on":[23,101,125],"this":[24],"has":[26],"been":[27],"limited.":[28],"Facilitation":[29],"NMDA":[31,50,54,85],"function":[33],"by":[34,111,176,191],"co-agonists":[35],"(D-serine":[36],"or":[37],"glycine)":[38],"only":[39],"partially":[40,195],"alleviates":[41],"symptoms":[43,242],"schizophrenia;":[45],"other":[46],"means":[47],"to":[48,169,185],"facilitate":[49],"receptors":[51,86,229],"are":[52],"required.":[53],"sub-types":[56],"differ":[57],"their":[59],"subunit":[60],"composition,":[61],"with":[62],"varied":[63],"GluN2":[64],"subunits":[65],"(GluN2A-GluN2D)":[66],"imparting":[67],"different":[68],"physiological,":[69],"biochemical":[70],"and":[71,108,116,198,201,240],"pharmacological":[72],"properties.":[73],"CIQ":[74,98,121,144,193,205],"is":[75,81],"a":[76,216],"positive":[77,239],"allosteric":[78],"modulator":[79],"that":[80,140,225],"selective":[82],"for":[83,237],"GluN2C/GluN2D-containing":[84,228],"(Mullasseril":[87],"et":[88],"al.).":[89],"EXPERIMENTAL":[90],"APPROACH:":[91],"The":[92,118],"effect":[93,119],"systemic":[95,141],"administration":[96,113,142],"was":[99,122,173,189],"tested":[100,124],"impairment":[102,127],"prepulse":[104],"inhibition":[105],"(PPI),":[106],"hyperlocomotion":[107,200],"stereotypy":[109],"induced":[110],"i.p.":[112],"MK-801":[115,151,164],"methamphetamine.":[117],"also":[123,194],"MK-801-induced":[126,208],"working":[129,209],"memory":[130,210],"Y-maze":[132],"spontaneous":[133,213],"alternation":[134,214],"test.":[135],"KEY":[136],"RESULTS:":[137],"We":[138],"found":[139],"(20":[145],"mg\u00b7kg\u207b\u00b9,":[146,153,159],"i.p.)":[147],"mice":[149],"reversed":[150,175,190,206],"(0.15":[152],"i.p.)-induced,":[154,160],"but":[155],"not":[156,174],"methamphetamine":[157,180],"(3":[158],"deficit":[161,211],"PPI.":[163],"increased":[165],"startle":[167,183],"amplitude":[168,184],"pulse":[170,186],"alone,":[171,187],"which":[172,188],"CIQ.":[177,192],"In":[178],"contrast,":[179],"reduced":[181],"attenuated":[196],"MK-801-":[197],"methamphetamine-induced":[199],"stereotyped":[202],"behaviours.":[203],"Additionally,":[204],"Y-maze.":[217],"CONCLUSION":[218],"IMPLICATIONS:":[220],"Together,":[221],"these":[222],"results":[223],"suggest":[224],"facilitation":[226],"may":[230],"serve":[231],"as":[232],"an":[233],"important":[234],"therapeutic":[235],"strategy":[236],"treating":[238],"cognitive":[241],"schizophrenia.":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1551425670","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
